Tisagenlecleucel

Tisagenlecleucel - Psychology, Special Needs, Health - Posted: 4th May, 2018 - 12:55pm

Text RPG Play Text RPG ?
 

Posts: 1 - Views: 130
Reply Add Reply
Drug for adults with relapsed or refractory large B-cell lymphoma
Post Date: 4th May, 2018 - 12:55pm / Post ID: #

Avatar
NOTE: News [?]

Tisagenlecleucel

FDA approved tisagenlecleucel (KYMRIAH, Novartis Pharmaceuticals Corp.) a CD19-directed genetically modified autologous T-cell immunotherapy, for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, high grade B-cell lymphoma and DLBCL arising from follicular lymphoma. Source 5h.

Sponsored Links:


Comment Add Comment As A Guest
 
> TOPIC: Tisagenlecleucel
« Next Oldest | Psychology, Special Needs & Health | Next Newest »
 

▲ TOP


International Discussions Coded by: BGID®
ALL RIGHTS RESERVED Copyright © 1999-2024
Disclaimer Privacy Report Errors Credits
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in our Cookies used here: Privacy / Disclaimer,